Maternal mortality risk factor in pregnancy with heart disease at Dr. Soetomo General Hospital, Surabaya, Indonesia
Downloads
Objectives: This research want to identify some factors that increasing risk of maternal death in pregnant woman with heart disease.
Materials and Methods: This study was a retrospective analytic study with cross sectional design, with total sampling 92 patient with heart disease in pregnancy at maternity room Dr. Soetomo hospital, Surabaya, during periode January until December 2017.
Results: Prevalency of pregnancy with heart disease in dr. Soetomo hospital about 0,5% with mortality that caused by heart disease 14% from all maternal death. Factors that increase risk of maternal death are non adequate antenatal visit number (OR 1,7;CI 95%), delay of detecting heart disease (OR 2,5;CI 95%), complication such as severe pulmonal hypertension (OR 61,4;CI 95%), Eisenmenger syndrome (OR 2,9;CI 95%), Decompensatio Cordis Functional Class IV (OR 1,2;CI 95%), and Thrombo-embolism (OR 9;CI 95%).
Conclusion: Mortality rate in pregnancy with heart disease is 14% of all maternal mortality. Risk of maternal death increased by non adequate antenatal visit and delay in heart disease detection, and also medical complications. Detection of heart disease since before pregnant with pre-conceptional councelling and a good managed multidisciplinary antenatal care supposed to decrease morbidity and mortality.Sawhney H, Aggarwal N, Suri V, Vasishta K,: Maternal and perinatal outcome in rheumatic heart disease. Int J Gynaecol Obstet 2003, 80
Bhatla N, Lal S, Behera G, Kriplani A, Mittal S, Agarwal N, Talwar KK: Cardiac disease in pregnancy. Int J Gynaecol Obstet 2003, 82
Cantwel R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D,et al. Saving Mothers' lives: reviewing maternal deaths to make motherhood safer: 2006–2008. BJOG 2011;118–203.
Siu SC, Sermer M, Colman JM, Alvarez AN, Mervier LA, Morton BC,et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515–21.
Balint OH, Siu SC, Mason J, et al. Cardiac outcomes after pregnancy in women with congenital heart disease. Heart 2010;96:1656–61.
Lui H, Xu JW, Zhao XD, Ye TY, Lin JH, Lin QG. Pregnancy outcomes in women with heart disease. Chin Med J 2010;123(17):2324–30.
Carole A. Warnes, MD. Pregnancy and Delivery in Women With Congenital Heart Disease, Circulation Journal Official Journal of the Japanese Circulation Society, Circulation Journal Vol.79, 2015
D. P. Naidoo, D. K. Desai, J. Moodley, Maternal deaths due to pre-existing cardiac disease, Cardiovascular Journal Of South Africa Vol 13, No. 1, 2002
Sarah A. Goldstein & Cary C. Ward, Congenital and Acquired Valvular Heart Disease in Pregnancy, Curr Cardiol Rep, 2017,19:96 DOI 10.1007/s11886-017-0910-6
Deanfield J, Thaulow E, Warnes C, et al. Management of grown up congenital heart disease. Eur Heart J. 2003;24:1035–1084. doi: 10.1016/S0195-668X(03)00131-3.
Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J. 2011; Aug 26 (Epub ahead of print; doi:10.1093/eurheartj/ehr218)
Yap SC, Drenthen W, Pieper PG, et al. On behalf of the ZAHARA Investigators. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol. 2008;126:240–246. doi: 10.1016/j.ijcard.2007.03.134.
Balci A, Drenthen W, Mulder BJ, et al. Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events. Am Heart J. 2011;161:307–313. doi: 10.1016/j.ahj.2010.10.027.
Newstead-Angel J, Gibson PS. Cardiac drug use in pregnancy: safety, effectiveness and obstetric implications. Expert Rev Cardiovasc Ther. 2009;7:1569–1580. doi: 10.1586/erc.09.152.
Kovavisarach E, Nualplot P. Outcome of pregnancy among parturients complicated with heart disease in Rajavithi hospital. J Med As Thai. 2007;90(11):2253–2259. DOI 10.1007/s12471-011-0188-z
Fernandes SM, Arendt KA, Landsberg MJ, et al. Pregnant women with cardiac disease: cardiac, anesthetic and obstetrical implications. Expert Rev Cardiovasc Ther. 2010;8:439–448. doi: 10.1586/erc.09.179.
Emily Gelson, Ruth Curry, Michael A. Gatzoulis, MD, PhD, Lorna Swan, MD, PhD, Martin Lupton,Philip Steer, MD, and Mark Johnson, PhD, Effect of maternal heart disease on fetal growth.Obstet Gynecol. 2011 Apr;117(4):886-91. doi: 10.1097/AOG.0b013e31820cab6
Weiss BM, Zemp L, Seifert B. Outcome of pulmonary vascular disease in pregnancy: a systematic review from 1978 through 1996. J Am Coll Cardiol. 1998;31:1650–1657. doi: 10.1016/S0735-1097(98)00162-4
WHO Guidelines Approved by the Guidelines Review Committee: WHO recommendations on antenatal care for a positive pregnancy experience, Geneva: World Health Organization; 2016.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
